RIGL Competitors & Alternatives

Compare Rigel Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

RIGL

Main Stock
$38.72
Tradestie Score
54
Market Cap
$505.12M
P/E Ratio
2.0
Revenue Growth
0.1%
Analyst Upside
+40.0%

Top Competitors

235 stocks in Biotechnology
Company Price Market Cap P/E Score Action
AVBP ArriVent BioPharma, Inc. Common Stock
$34.67
$748.90M - 58 Compare
TBPH Theravance Biopharma, Inc.
$16.93
$726.21M 7.6 59 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$23.97
$718.62M - 58 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$30.62
$715.25M - 56 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$146.76
$699.30M - 59 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$7.34
$688.47M - 57 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ANL ANL
$9.49
$682.62M - 58 Compare
ARVN Arvinas, Inc
$8.39
$670.30M - 51 Compare

Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)

235 stocks in this industry